COVID-19: Information for Media/Press
The 2019 novel coronavirus disease (COVID-19) is a virus of global health significance caused by infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is thought to spread from person to person in close contact through respiratory droplets. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic.
At BioReference, our priority remains in the health and safety of our employees, and the healthcare providers, patients and communities we serve, and we are doing our part to deliver answers during these uncertain times.
Thank you for your interest in speaking with BioReference about the COVID-19 pandemic, and our company’s test capabilities and response.
To help support patients, providers, employers and government agencies in the fight against the COVID-19, BioReference has completed the following:
3/13: Collaborated with the New York State Department of Health and Governor Andrew M. Cuomo to provide testing for the first public drive-through testing facility on the East Coast, located in New Rochelle, NY, the epicenter for the New York State outbreak. Additional satellite testing sites to be set-up in the coming weeks.
Read the Governor’s Office statement
3/4: Attended a meeting with Vice President Mike Pence, members of the White House’s Coronavirus Task Force, The American Clinical Laboratory Association (ACLA) and other diagnostic laboratory leaders from across the nation to discuss the critical issues related to coronavirus disease testing capacity as the demand for testing in America grows.
Read the ACLA statement
We continue to closely monitor and respond to this rapidly evolving situation. Please continue to visit this page for the most up-to-date information.